ZYUS Life Sciences Completes Secured Loan Financing

MT newswire2026/09/01 17:26

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

01:26 PM EDT, 09/01/2026 (MT Newswires) -- ZYUS Life Sciences' (ZYUS.V) wholly-owned subsidiary, ZYUS Life Sciences Inc, completed its secured loan financing and raised gross proceeds of around C$1.9 million, it said after markets closed Monday. The secured loan, completed in nine tranches, has an interest rate of 12% per annum, is prepayable at any time without penalty or premium, and matures six months from the effective date of each loan, said the company. Certain insiders took part in the secured loan for a total of C$845,000, added the company. The company's shares last traded May 6, closing at C$0.495 on the TSX Venture Exchange.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.

华尔街见闻•2026/11/10 18:41